Market Research Logo

Exact Sciences Corp (EXAS) - Product Pipeline Analysis, 2019 Update

Summary

Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a US FDA approved non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates manufacturing and laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Exact Sciences Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Exact Sciences Corp Company Overview
Exact Sciences Corp Company Snapshot
Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview
Exact Sciences Corp – Pipeline Analysis Overview
Business Description
Exact Sciences Corp - Key Facts
Exact Sciences Corp - Major Products and Services
Exact Sciences Corp Pipeline Products by Development Stage
Exact Sciences Corp Pipeline Products Overview
Blood-based Liver Cancer Test
Blood-based Liver Cancer Test Product Overview
Blood-based Lung Cancer Screening Test
Blood-based Lung Cancer Screening Test Product Overview
Diagnostic Assay - Esophageal Cancer
Diagnostic Assay - Esophageal Cancer Product Overview
Diagnostic Assay - Pancreatic Cancer
Diagnostic Assay - Pancreatic Cancer Product Overview
DNA Biomarkers - Hepatocellular Carcinoma
DNA Biomarkers - Hepatocellular Carcinoma Product Overview
DNA Integrity Assay
DNA Integrity Assay Product Overview
Liquid Biopsy Test - Bladder Cancer
Liquid Biopsy Test - Bladder Cancer Product Overview
Liquid Biopsy Test - Breast Cancer
Liquid Biopsy Test - Breast Cancer Product Overview
Liquid Biopsy Test - Cervical Cancer
Liquid Biopsy Test - Cervical Cancer Product Overview
Liquid Biopsy Test - Kidney Cancer
Liquid Biopsy Test - Kidney Cancer Product Overview
Liquid Biopsy Test - Lymphoma
Liquid Biopsy Test - Lymphoma Product Overview
Liquid Biopsy Test - Melanoma
Liquid Biopsy Test - Melanoma Product Overview
Liquid Biopsy Test - Ovarian Cancer
Liquid Biopsy Test - Ovarian Cancer Product Overview
Liquid Biopsy Test - Prostate Cancer
Liquid Biopsy Test - Prostate Cancer Product Overview
Liquid Biopsy Test - Stomach Cancer
Liquid Biopsy Test - Stomach Cancer Product Overview
Liquid Biopsy Test - Uterine Cancer
Liquid Biopsy Test - Uterine Cancer Product Overview
PreGen-Plus
PreGen-Plus Product Overview
Exact Sciences Corp - Key Competitors
Exact Sciences Corp - Key Employees
Exact Sciences Corp - Key Employee Biographies
Exact Sciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exact Sciences Corp, Recent Developments
May 20, 2019: Exact Sciences Advances Pipeline Capabilities With Mayo Clinic
May 17, 2019: Exact Sciences presents new data reinforcing performance of Cologuard
Apr 30, 2019: First-quarter revenue and cologuard test volume increased 79 percent to $162 million and 334,000, respectively
Mar 19, 2019: Kathleen Sebelius appointed to Exact Sciences Board
Feb 27, 2019: Cologuard Helps Screen Two Million People for Colorectal Cancer
Feb 21, 2019: Total 2018 revenue increased 71 percent to $454 million, and 934,000 people were screened with Cologuard
Feb 21, 2019: 2019 Cologuard Classic Ups the Ante with New 'Hole-In-One Attendance Challenge' to drive awareness of colorectal cancer and importance of early detection
Jan 07, 2019: Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018
Oct 30, 2018: Exact Sciences announces third quarter 2018 financial results
Oct 30, 2018: Cologuard revenue increased 63 percent to $118 million, and Cologuard test volume grew 49 percent to 241,000 during third quarter
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview
Exact Sciences Corp Pipeline Products by Equipment Type
Exact Sciences Corp Pipeline Products by Indication
Exact Sciences Corp, Key Facts
Exact Sciences Corp, Major Products and Services
Exact Sciences Corp Number of Pipeline Products by Development Stage
Exact Sciences Corp Pipeline Products Summary by Development Stage
Blood-based Liver Cancer Test - Product Status
Blood-based Liver Cancer Test - Product Description
Blood-based Lung Cancer Screening Test - Product Status
Blood-based Lung Cancer Screening Test - Product Description
Diagnostic Assay - Esophageal Cancer - Product Status
Diagnostic Assay - Esophageal Cancer - Product Description
Diagnostic Assay - Pancreatic Cancer - Product Status
Diagnostic Assay - Pancreatic Cancer - Product Description
DNA Biomarkers - Hepatocellular Carcinoma - Product Status
DNA Biomarkers - Hepatocellular Carcinoma - Product Description
DNA Integrity Assay - Product Status
DNA Integrity Assay - Product Description
Liquid Biopsy Test - Bladder Cancer - Product Status
Liquid Biopsy Test - Bladder Cancer - Product Description
Liquid Biopsy Test - Breast Cancer - Product Status
Liquid Biopsy Test - Breast Cancer - Product Description
Liquid Biopsy Test - Cervical Cancer - Product Status
Liquid Biopsy Test - Cervical Cancer - Product Description
Liquid Biopsy Test - Kidney Cancer - Product Status
Liquid Biopsy Test - Kidney Cancer - Product Description
Liquid Biopsy Test - Lymphoma - Product Status
Liquid Biopsy Test - Lymphoma - Product Description
Liquid Biopsy Test - Melanoma - Product Status
Liquid Biopsy Test - Melanoma - Product Description
Liquid Biopsy Test - Ovarian Cancer - Product Status
Liquid Biopsy Test - Ovarian Cancer - Product Description
Liquid Biopsy Test - Prostate Cancer - Product Status
Liquid Biopsy Test - Prostate Cancer - Product Description
Liquid Biopsy Test - Stomach Cancer - Product Status
Liquid Biopsy Test - Stomach Cancer - Product Description
Liquid Biopsy Test - Uterine Cancer - Product Status
Liquid Biopsy Test - Uterine Cancer - Product Description
PreGen-Plus - Product Status
PreGen-Plus - Product Description
Exact Sciences Corp, Key Employees
Exact Sciences Corp, Key Employee Biographies
Exact Sciences Corp, Subsidiaries
Glossary
List of Figures
Exact Sciences Corp Pipeline Products by Equipment Type
Exact Sciences Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook